Sign in
AGE Stock Price, Chart, Stats & News
AgeX Therapeutics, Inc.
Save
27.76M
Market cap
–
Current P/E
–
Forward P/E
AGE chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | -18478.46% |
Pretax margin | -14766.92% |
Net margin | -14950.77% |
Effective tax rate | 0.09% |
ROA | -279.61% |
ROE | -1487.64% |
D/E | -5.30x |
Interest coverage ratio | 131.27x |
AGE valuation
P/E | – |
P/S | 213.53x |
P/B | -3057.00x |
P/CF | -6.30x |
P/FCF | -1.55x |
P/OCF | -6.30x |
PEG | -0.06x |
EV multiple | -1.38x |
About
AgeX Therapeutics, Inc. is a U. S.-based biotechnology company dedicated to pioneering and commercializing groundbreaking therapies that address human aging and degenerative conditions. The company's developmental pipeline features several promising cell-based therapeutic candidates: AGEX-BAT1: A cell therapy designed to manage various age-related metabolic disorders, including adult-onset Type II diabetes and obesity.
Similar securities
Based on sector and market capitalization
Report issue